Xs2HiTek-workshop 'Diagnostiek in de Pathologie' 2014
Tispa Medical supports this conference and will be present for interactive communication about standardisation in Tissue Processing.
The event will take place in Aalborg from June 5 to June 7.
Click on this news item for a link to the conference website
Tispa Medical will present their innovation in tissue processing on the Bamberger Morphologietage.
When? January 18 and 19
Where? Welcome Kongresshotel Bamberg
Tispa Medical is a guest on the exhibition booth 30 of Slee Medical
Tispa Medical will present their innovation in tissue processing in Utrecht during the Pathology Winter Meeting.
When? January 7 and 8
Based on experience with the first installed processors we have been able to substantially reduce the process times and CO2 consumption. We have also managed to successfully process thicker fat tissues of up to 5mm. The process time: biopsies is 1:30, samples up to 4mm is 3:30 and samples of 5mm is 4:10. The Tispa Processor only uses ethanol 99%, CO2 and paraffine, fresh reagents are used each run creating a constant output in quality.
Tispa Medical will be present at the Morphologietagen in Kassel on September 28 and 29.
We will be a guest at the Slee Medical Booth.
We invite everybody to visit us there, see the Tispa Processor I and learn all about improved safety and quality in tissue processing.
The 2012 European Conference of Pathology will take place in picturesque Prague.
Of course Tispa Medical will be present to show cutting edge tissue processing, safer, faster and with improved results.
Visit us for a personal introduction and a tour of the machine on
Aims: Xylene is most often employed in tissue processing protocols for paraffin embedding, but poses a health hazard. Here a solvent-free processing protocol is described using supercritical carbondioxide (scCO2) as an intermediate.
Materials and Results: Series of tests (with bovine tissues) were run evaluating the dehydration and tissue shrinkage in our new scCO2-based protocol compared with routine processing using a graded ethanol and xylene series. Then a series of tests was run to evaluate the significance of processing parameters on the outcome. Finally, a validation series was performed using optimal conditions, testing various human tissues with several staining methods. The tissue water content after paraffination was the same using our new scCO2-based and routine xylene-based protocols. Tissue shrinkage was comparable using the 2 methods, around 15%, which is also comparable with the literature. In the validation series, the human tissues showed good morphology with strong staining probably based on stronger antigenicity.
Conclusions: This scCO2-based protocol is concluded to be a good solvent-free, alternative form of tissue processing. Although not the focus of this paper, this new protocol can process tissues within 4 hours, without the need to change macroscopy/sectioning protocols.
© 2012 Blackwell Publishing Ltd
Tispa Medical invites you to their booth 5b37 to introduce you to the new non-toxic tissue processor.
With the installation of the first Tispa Processor in their pathology laboratory, the Erasmus MC takes an important step in eliminating the use of toxic solvents.
On May 16 Tispa Medical will actively participate in the workshop organised by the Dutch branche organisation FHI. The workshop is sub-titled:
Diagnostics in pathology - Roadmap to the future.
The workshop features scientific introductions by Prof. Dr. R.R. de Krijger of Erasmus Medical Centre on practical experiences of the pathologist tissue diagnosis, with an emphasis on streamlining the workflow.
Sanbio BV will inform us on developments of Biotech companies to new developments in pathology, mainly on moleclar research.
Dr. E. Schuuring of the University Medical Centre Groningen (UMCG) will elaborate on the scientific side of molecular pathology.
The Dutch Pathology days, 'Pathologendagen', will be held this year on April 14 and 15 in the beautiful venue of Hotel Figi in Zeist.
Tispa Medical will participate as sponsor to promote and introduce the Tispa Processor I. This processor is the first in the world to eliminate the toxic and dangerous so-called 'clearing phase' in tissue processing with a patented application of harmless CO2 (carbon dioxide).
Tispa Medical Rapid Processing - Safe, clean and fast
The best possible results on all types of tissue and all types of staining, both routine H&E and (immuno) histochemical. Excellent results on PCR extraction and other molecular techniques.
Op zaterdag 26 maart vond het voorjaarscongres van de VAP, de Vereniging van Analisten in de Pathologie, plaats in Ermelo.
Tispa Medical gaf hier acte de présence met de presentatie van Tispa Processor I. Deze processor is de eerste ter wereld die de toxische en gevaarlijke zogenaamde 'clearing phase' in de weefseldoorvoer geheel overbodig maakt door innovatief gebruik van CO2, kooldioxide.
In January 2011 the clinical validation of the Tispa Processor I was completed successfully.
A complete test cycle, in compliance with the Medical Device Directive IVDD 98/76 EC, was performed in the pathology lab of the UMCG (University Medical Centre Groningen).
The Tispa Processor I is now an IVD compliant Medical Device and available to all pathology laboratories.
Tispa Medical rapid processing - safe, clean and fast. No xylene or other organictoxic solvents. Ethanol - CO2 - paraffin, that's it, that's all.
Tispa Medical is proud to announce that the solvent free and fast histological processing method is now patented in the United States. This opens promising opportunities for expansion of the company.
The Tispa Medical process is featured in the October/November 2009 issue of the German magazine Regionaleuropäischer Wirtschafts-Spiegel. Read more and find the link
Tispa Medical internationally represented by Nikon Instruments